Clinical Trial Update: Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of suvorexant in participants with hepatic insufficiency completed; assesses how liver impairment affects drug exposure in insomn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency
• Insomnia

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Insomnia, Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2014-08-29